Clinical Trial Update: Safety and Efficacy Study of Thalomid in Patients With Chronic Pancreatitis [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of thalidomide (Thalomid) in chronic pancreatitis was terminated; no final efficacy results are described in the summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• Thalomid (thalidomide)

Snippet

Sponsor: Winthrop University Hospital | Conditions: Chronic Pancreatitis | Phase 2 | Status: TERMINATED